Celeste Krewson, Assistant Editor

Orphagen Pharmaceuticals has announced their drug OR-499 received a rare pediatric disease designation for treating pediatric adrenocortical carcinoma from the US Food and Drug Administration.

A survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health showed how parents get the most out of their children’s well visits.

The American Academy of Pediatrics has released a new policy statement on how health care providers can meet the needs of hospitalized adolescents.

Cindy Jackson, DO, FAAP, discusses the creation of the Spin to Save Kids challenge for bringing awareness to the disparities in pediatric drug development.

In a recent study, children had improved short- and long-term mortality when treated in emergency departments with high pediatric readiness.

Colleen Kraft, MD, senior medical director of clinical adoption at Cognoa, discusses how autism spectrum disorder (ASD) development affects children and families, along with how early diagnosis and treatment can improve the lives of children with ASD.

In a recent study, young children with severe traumatic brain injury (TBI) showed significantly worse cognition and academic scores than children with mild TBI or other injury.

Nearly $245 million was awarded in Bipartisan Safer Communities Act funding from the US Department of Health and Human Services to help health care workers support mental health in youths and families.

A recent study found that a family history of autoimmune diseases increased risk factors in juvenile idiopathic arthritis development.

In a recent study, young children with developmental delay saw improvements in behavior after receiving treatment through telehealth.

A recent study found a rise in the prevalence of antipsychotic prescriptions among pediatric patients and noted which antipsychotics were most commonly used for specific indications.

In a recent study, children with spinal muscular atrophy were more often able to walk when diagnosed through newborn screening and provided with early treatment.

The Centers for Disease Control and Prevention has provided an updated safety profile on the bivalent COVID-19 booster vaccine in children aged 5 to 11 years, showing similar adverse events to the monovalent vaccine.

A follow-up to a Texas Sprouts gardening intervention found improved glucose control and reduced low-density lipoprotein cholesterol in individuals at a high risk of metabolic diseases.

A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.

A follow-up of a trial cohort showed that children aged 5 years born to pregnant smokers had improved airway function when vitamin C supplementation was administered during pregnancy compared to placebo.

In a recent study, sugar warnings and a lack of misleading front-of-package marketing reduced the proportion of caregivers who selected sugar-sweetened beverages for young children.

Arthrex’s TightRope implant for treating pediatric anterior cruciate ligament (ACL) injuries has received clearance from the US Food and Drug Administration.

While an economic evaluation showed reduced costs for school screening and optometric examination strategies, these changes were not significant when compared to primary care screening.

A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.

The National Institutes of Health has given 8 research grants for refining new technologies to provide early diagnosis of severe illness associated with COVID-19 infection in children.

A phase 3 trial of lomitapide showed safety and efficacy for treating homozygous familial hypercholesterolemia (HoFH) in pediatric patients aged 5 to 17 years.

The February 2023 edition of Pediatrics included evidence-based guidelines from the American Academy of Pediatrics on evaluating and treating obesity in children and adolescents.

VERO Biotech Inc has announced a US Food and Drug Administration approval for the third generation of their tankless Genosyl Delivery System.

Patients with a history of multisystem inflammatory syndrome in children (MIS-C) completed a questionnaire about adverse reactions following COVID-19 vaccination, and no serious adverse events were recorded.

A recent study found that children were more likely to present with high BMI and obesity if they had low Child Opportunity Index scores early in life.

Recent research projects the prevalence of type 1 and type 2 diabetes among youths will rise through 2060.

The US Food Administration has agreed to review an application for nirsevimab (Beyfortus; AstraZeneca and Sanofi) to protect infants against RSV.

In a recent study, it was found adolescents who frequently checked social media had a lower neural sensitivity to social anticipation.

In a recent study, it was found that children with medical complexity are at a greater risk of overweight and obesity compared to children without medical complexity.